Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
151,865,218
-
Total 13F shares
-
78,227,891
-
Share change
-
+78,123,950
-
Total reported value
-
$3,735,238,853
-
Price per share
-
$48.30
-
Number of holders
-
109
-
Value change
-
+$3,730,992,062
-
Number of buys
-
108
Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q2 2019
As of 30 Jun 2019,
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,227,891 shares.
The largest 10 holders included
Viking Global Investors LP, Matrix Capital Management Company, LP, Senator Investment Group LP, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., BAMCO INC /NY/, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and FMR LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.